BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180322
DTEND;VALUE=DATE:20180424
DTSTAMP:20260729T181649
CREATED:20180322T102038Z
LAST-MODIFIED:20180322T102038Z
UID:19814-1521676800-1524527999@ces.b2sg.org
SUMMARY:Clinical Research Scientist
DESCRIPTION:This position is responsible for working with the physicians and cross functions within Clinical Development to provide clinical research support for programs as assigned by phase. \nResponsibilities \nIn collaboration with cross functional teams performs the following: \n\nDevelops protocols and informed consent documents for clinical studies\nAnalyzes and works with clinical data\nDrafts clinical scientific documents such as IND\, IND amendments\, Investigator Brochures\, and other documents for FDA/EMA submissions\nContributes actively in the CSR preparation and finalization\nMonitors\, & reviews along with the medical monitor safety and efficacy data in ongoing studies; monitors GCP compliance with help of clinical operations and CRO\nContributes to the development of CRFs\nAnswers along with the medical monitor patient eligibility questions from CRO and site and questions from IRB/EC and health authorities\nMay have a leadership role in the matrix teams for assigned compounds\nDevelops and maintains relationships with appropriate KOLs\, investigators\, cooperative groups\, and patient advocacies. Serves as first point of contact for medical questions from sites\nAssists and/or writes with clinical abstracts\, assists and/or presents data at scientific meetings\, SIVs; conducts protocol training\nParticipates with clinical operations in the CRO/vendor selection and bidding\nKeeps abreast of oncology treatment modalities\, drug mechanism of action\, approaches to drug development and regulatory requirements\nActs as a clinical representative in variety of cross-functional teams\n\nQualifications \n\nDegree in scientific/life-sciences/clinical/nursing field. M.S.\, Ph.D. preferred\nPrior hematology or oncology drug development experience is highly desired\nAbility to multi-task well\, to deal well with conflict and obstacles\, and to work in a fast-paced environment\nExcellent written and oral communication skills\nStrong analytical ability
URL:https://ces.b2sg.org/event/epizyme-22mar18/
LOCATION:Epizyme\, 400 Technology Square\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/06/epizyme.jpg
END:VEVENT
END:VCALENDAR